Initial Safety and Preliminary Efficacy of the Novelrad Vascular Closure System (NVCS)
NCT: NCT07858903 · COMPLETED
Brief Summary
This study evaluates the initial safety and preliminary efficacy of the Novelrad Vascular Closure System (NVCS), a suture-mediated vascular closure system, in achieving post-procedure hemostasis in subjects undergoing interventional catheterization procedures through the common femoral artery using large-bore procedural sheaths.
Frequently Asked Questions
What is Initial Safety and Preliminary Efficacy of the Novelrad Vascular Closure System (NVCS)?
Initial Safety and Preliminary Efficacy of the Novelrad Vascular Closure System (NVCS) is a clinical trial registered under NCT07858903. Current status: COMPLETED.
What is the status of NCT07858903?
The current status of NCT07858903 (Initial Safety and Preliminary Efficacy of the Novelrad Vascular Closure System (NVCS)) is: COMPLETED.
When did Initial Safety and Preliminary Efficacy of the Novelrad Vascular Closure System (NVCS) start?
Initial Safety and Preliminary Efficacy of the Novelrad Vascular Closure System (NVCS) started on 2025-11-30.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.